Transcriptomics Based Network Analyses and Molecular Docking Highlighted Potentially Therapeutic Biomarkers for Colon

Yun Wu1, Xiaoping Dong1, Jia Hu2

  • 1National & Local Joint Engineering Laboratory of Animal Peptide Drug Development, College of Life Sciences, Hunan Normal University, Changsha, 410011, Hunan, China.

Biochemical Genetics
|January 16, 2023
PubMed

Insights

Machine learning identified key genes in colon cancer by analyzing transcriptomics data. Four novel biomarkers (ACOX1, CPT2, CDC25C, PKMYT1) show potential for diagnosis and treatment.

Area of Science:

  • Bioinformatics
  • Genomics
  • Oncology

Background:

  • High-throughput transcriptomics data offers insights into complex diseases.
  • The TCGA database provides a valuable resource for cancer research.

Purpose of the Study:

  • To mine TCGA transcriptomics data for colon cancer using machine learning.
  • To identify novel biomarkers and potential therapeutic targets for colon cancer.

Main Methods:

  • Machine learning-based bioinformatics analysis.
  • Differential gene expression analysis.
  • Gene co-expression network analysis.
  • Survival analysis and drug prediction.

Main Results:

  • Identified 2469 differentially expressed genes in colon cancer.
  • Highlighted genes related to cell cycle, metabolism, and fatty acid degradation.
  • Discovered significant correlations between gene sets and colon cancer progression.
  • Proposed ACOX1, CPT2, CDC25C, and PKMYT1 as novel colon cancer biomarkers.

Conclusions:

  • The identified biomarkers and drug targets offer potential for colon cancer prevention, diagnosis, and treatment.
  • This study provides valuable insights for clinical applications in colon cancer management.

Related Concept Videos